| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |